Trial Details

RECRUITING
Basic Information
Clinical ID c632
Identifier NCT06298188
Trial Title Risankizumab in Children With Crohn's Disease (RisaKids)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions DRUG: Risankizumab
Participant Information
Sponsor Shaare Zedek Medical Center
City Jerusalem
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2024-10-31
Primary Completion Date 2026-10
Completion Date 2026-10